Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 703.06

-2.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (704)	11/11/2002 7:07:44 PM
From: Miljenko Zuanic	Read Replies (1) of 3559

With Xenical problems surfacing, and Meridia with is own problems, obesity market is wide open. Dow Jones Business News Swiss Insurers Drop Roche's Xenical From Basic Coverage Monday November 11, 6:01 am ET ZURICH -(Dow Jones)- The anti-obesity drug Xenical, which is manufactured by Swiss pharmaceutical company Roche Holding AG , will no longer be covered by basic health insurance in Switzerland, effective Jan. 1, 2003. According to Swiss health insurance laws, only drugs that are absolutely necessary should fall under the coverage of basic insurance. Santesuisse, an association of Swiss health insurers, said Xenical doesn't meet this criteria. The association added that necessary proof of the drug's effectiveness isn't available. -By Carey Sargent, Dow Jones Newswires; +41 1 211 6637; carey.sargent@dowjones.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next